|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $2,343,518 as of June 30, 2026 and $2,362,847 as of March 31, 2026 | ||||||||||||||||||||
| Total accounts receivable, net of allowance for credit losses of $2,343,518 as of June 30, 2026 and $2,362,847 as of March 31, 2026 | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due from related parties | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets - discontinued operations | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Patents, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Patents | ||||||||||||||||||||
| Other Intangible Assets | ||||||||||||||||||||
| Total intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Right of use assets - operating leases | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Noncurrent assets held for sale | ||||||||||||||||||||
| Noncurrent assets - discontinued operations | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Notes payable - related parties, current maturities | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Note payable related party | ||||||||||||||||||||
| Total note payable related party | ||||||||||||||||||||
| Current portion of construction note payable | ||||||||||||||||||||
| Insurance premium note payable | ||||||||||||||||||||
| Current liabilities - discontinued operations | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term Liabilities: | ||||||||||||||||||||
| Contingent consideration payable | ||||||||||||||||||||
| Notes payable related party, net of current portion | ||||||||||||||||||||
| Notes payable - related parties, net of debt discounts of $1,913,216 as of June 30, 2026 and $1,963,771 as of March 31, 2026 | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Construction note payable, net of unamortized issuance costs | ||||||||||||||||||||
| Operating lease liability, net of current portion | ||||||||||||||||||||
| Deferred income tax liability | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Noncurrent liabilities held for sale | ||||||||||||||||||||
| Noncurrent liabilities - discontinued operations | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Series A cumulative perpetual preferred stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of June 30, 2026 and March 31, 2026 | ||||||||||||||||||||
| Common stock, $0.001 par value, 200,000,000 shares authorized; 119,479,220 and 119,346,452 shares issued and 116,015,388 and 116,902,624 shares outstanding at June 30, 2026 and March 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...